2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Cell Biopeutics Resources Sdn Bhd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease Stempeucel® - Critical Limb Ischemia, Peripheral Arterial Disease | Phase 4 | Recruiting | Cell Biopeutics Resources Sdn Bhd | 10 | 2024-01-01 | 2025-09-09 |
| Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells - Critical Limb Ischemia, Buerger's Disease | Phase 4 | Recruiting | Cell Biopeutics Resources Sdn Bhd | 3 | 2024-01-01 | 2025-09-09 |
Chronic Limb-Threatening Ischemia (2) · Peripheral Arterial Disease (1) · Thromboangiitis Obliterans (1)
Malaysia (2)